Cysteine Dioxygenase, Type I (CDO1) (Middle Region) Peptide
CDO1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all CDO1 products
- CDO1 (Cysteine Dioxygenase, Type I (CDO1))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- VEEVQAIMEA YESDPTEWAM YAKFDQYRYT RNLVDQGNGK FNLMILCWGE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- CDO1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CDO1 (Cysteine Dioxygenase, Type I (CDO1))
- Synonyms
- 1300002L19Rik Peptide, Cdo Peptide, D18Ucla3 Peptide, cysteine dioxygenase, type I Peptide, cysteine dioxygenase 1, cytosolic Peptide, cysteine dioxygenase type 1 Peptide, NAEGRDRAFT_80458 Peptide, Cdo1 Peptide, CDO1 Peptide
- Background
-
Initiates several important metabolic pathways related to pyruvate and several sulfurate compounds including sulfate, hypotaurine and taurine. Critical regulator of cellular cysteine concentrations. Has an important role in maintaining the hepatic concentation of intracellular free cysteine within a proper narrow range.
Protein Size: 200 - Gene ID
- 1036
- NCBI Accession
- NM_001801, NP_001792
- UniProt
- Q16878
-
You are here:
